Expanded Access for Repotrectinib
Status
Treatments
Drug: Repotrectinib
Details and patient eligibility
About
This is an expanded access designed to provide access to Repotrectinib for eligible participants.
Sex
Volunteers
No Healthy Volunteers
Inclusion criteria
Exclusion criteria
Trial contacts and locations
0
Loading...
Central trial contact
BMS Study Connect Contact Center http://www.bmsstudyconnect.com; First line of the email MUST contain NCT # and Site #.
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal
© Copyright 2026 Veeva Systems